Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Anim Hosp Assoc ; 34(1): 74-8, 1998.
Article in English | MEDLINE | ID: mdl-9527433

ABSTRACT

Physaloptera infections were diagnosed endoscopically in 18 dogs. Each case had vomiting as the primary clinical sign, and four cases had regurgitation as a concurrent sign. Fecal flotations, using magnesium sulfate solution, were performed in 12 of the 18 cases and were negative for Physaloptera eggs. In 12 of the 18 cases, only one worm was seen during endoscopic examination. Fifteen of 18 cases were treated with pyrantel pamoate, and 10 of 12 cases with follow-up had resolution of their vomiting.


Subject(s)
Antinematodal Agents/therapeutic use , Dog Diseases , Pyrantel Pamoate/therapeutic use , Spirurida Infections/veterinary , Spiruroidea , Vomiting/veterinary , Animals , Dogs , Duodenoscopy/veterinary , Female , Follow-Up Studies , Gastroscopy/veterinary , Male , Ohio , Spirurida Infections/diagnosis , Spirurida Infections/drug therapy , Spiruroidea/isolation & purification , Texas , Vomiting/etiology , Vomiting/parasitology
2.
J Vet Intern Med ; 11(4): 212-7, 1997.
Article in English | MEDLINE | ID: mdl-9298475

ABSTRACT

Muscle potassium content and supplementation with potassium gluconate were evaluated in normokalemic cats with chronic renal failure (CRF). Affected cats received standard medical therapy for renal failure and either placebo (sodium gluconate) or potassium gluconate. At the beginning of the study and after 6 months of supplementation, glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were estimated using 3H-inulin and 14C-tetraethylammonium bromide (TEA) clearances. Muscle potassium content was determined in biopsy specimens using atomic absorption spectroscopy. Muscle biopsy samples obtained from cats with CRF before treatment had significantly lower muscle potassium content than did those from normal control cats. Over the 6-month period of supplementation, muscle potassium content increased both in cats with CRF that received potassium gluconate and in those that received placebo (sodium gluconate). Serum potassium concentration and fractional excretion of potassium remained relatively unchanged in both groups of cats throughout the treatment period. There were no significant differences in the percentage change in GFR and ERPF between treatment groups over the 6-month time period. Median values for pH, HCO3-, and total CO2 at 6 months were higher than baseline in the potassium gluconate group but lower than baseline in the sodium gluconate group.


Subject(s)
Cat Diseases/metabolism , Gluconates/pharmacology , Kidney Failure, Chronic/veterinary , Muscle, Skeletal/chemistry , Potassium/analysis , Potassium/blood , Animals , Bicarbonates/blood , Carbon Radioisotopes , Cat Diseases/physiopathology , Cats , Dietary Supplements , Dose-Response Relationship, Drug , Female , Glomerular Filtration Rate/drug effects , Glomerular Filtration Rate/physiology , Gluconates/administration & dosage , Hydrogen-Ion Concentration , Inulin/pharmacokinetics , Kidney Failure, Chronic/metabolism , Kidney Failure, Chronic/physiopathology , Male , Metabolic Clearance Rate , Phosphorus/blood , Potassium/administration & dosage , Tetraethylammonium/pharmacokinetics , Time Factors , Tritium
3.
J Vet Intern Med ; 10(3): 110-5, 1996.
Article in English | MEDLINE | ID: mdl-8743208

ABSTRACT

Ultrasonographic evaluation of the adrenal glands was performed in 10 dogs with pituitary-dependent hyperadrenocorticism (PDH) and in 10 age- and weight-matched healthy control dogs. Thickness, shape, and echogenicity were determined for each adrenal gland. Adrenal thickness in dogs with PDH (median, 10 mm-left; 8.5 mm-right) was significantly greater than thickness in control dogs (median, 6 mm-left; 6 mm-right). Other ultrasonographic characteristics associated with PDH included bilaterally symmetrical adrenomegaly and maintenance of normal adrenal shape. Adrenal echogenicity was homogeneous and less than that of the adjacent renal cortex in 8 of 10 dogs with PDH and in 10 of 10 control dogs. Heterogenous echogenicity was present in 2 of 10 dogs with PDH, and was associated with nodular cortical hyperplasia in one of those dogs. Results of this study confirm the difference in sonographic appearance between PDH-induced bilateral cortical hyperplasia and functional adrenocortical neoplasia, and show a difference in sonographically determined adrenal size between healthy dogs and dogs with PDH.


Subject(s)
Adrenal Glands/diagnostic imaging , Adrenocortical Hyperfunction/veterinary , Dog Diseases/diagnostic imaging , Adrenocortical Hyperfunction/diagnostic imaging , Adrenocortical Hyperfunction/pathology , Animals , Dog Diseases/pathology , Dogs , Prospective Studies , Ultrasonography
4.
J Vet Intern Med ; 10(2): 65-71, 1996.
Article in English | MEDLINE | ID: mdl-8683482

ABSTRACT

Cavernous sinus syndrome (CSS) is characterized by deficits in more than one of the cranial nerves (CN) that traverse the cavernous sinus at the base of the cranial vault: CN III (oculomotor), IV (trochlear), VI (abducens), and the first two branches of CN V (trigeminal). Records from 4 dogs and 8 cats with CSS diagnosed over a 14-year period were reviewed. The most common clinical signs were ophthalmoparesis or ophthalmoplegia, mydriasis with no direct or consensual pupillary light reflexes, ptosis, decreased corneal sensation, and decreased retractor oculi reflex. All cats had initial signs referable to a left CSS lesion (one had bilateral CSS), whereas in all dogs the lesions were localized to the right cavernous sinus. Median ages at diagnosis were 9 and 10 years of age for dogs and cats, respectively. Cerebel lomedullary cisternae cerebrospinal fluid analysis in 6 animals was useful as a sensitivebut nonspecific diagnostic test of an intracranial inflammatory or neoplastic lesion. Magnetic resonance imaging scans provided a more definitive diagnostic test in all dogs, revealing a contrast-enhancing mass on T1 weighted scans in the region of the cavernous sinus. A definitive pathological diagnosis was obtained in 2 dogs: a primary intracranial neoplasm and a metastatic intracranial neoplasm. A definitive diagnosis was obtained in 6 cats: metastatic neoplasm (n = 1), primary intracranial neoplasm (n = 1), primary intracranial infectious disease (n = 2), and associated systemic infectious disease (n = 2). The prognosis associated with CSS in dogs and cats was considered guarded to poor.


Subject(s)
Cat Diseases/physiopathology , Cavernous Sinus/pathology , Cranial Nerve Diseases/veterinary , Dog Diseases/physiopathology , Animals , Cat Diseases/diagnosis , Cats , Cranial Nerve Diseases/diagnosis , Cranial Nerve Diseases/physiopathology , Dog Diseases/diagnosis , Dogs , Prognosis , Retrospective Studies , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...